JAK2 MutaSearch regulatory update

Ipsogen received CE Mark approval in the EU for its JAK2 MutaSearch and MutaQuant kits for myoproliferative disorders. The MutaSearch kit is designed to detect the janus kinase-2 (JAK-2) V617F mutati...